Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 424, pseudogene (RN7SL424P)

Target
RN7SL424P
Molecular classification
Other, Non-coding RNA pseudogene
01

Overview

RNA, 7SL, cytoplasmic 424, pseudogene (RN7SL424P) is a pseudogene derived from the 7SL RNA gene family. 7SL RNA is a highly conserved noncoding RNA component of the signal recognition particle (SRP), which is essential for guiding secretory proteins to the endoplasmic reticulum[1][4]. However, RN7SL424P is a truncated, non-functional copy of 7SL RNA and lacks protein-coding potential or known regulatory activity. The human genome harbors hundreds of 7SL-like pseudogenes, which are thought to arise by reverse transcription of 7SL RNA and subsequent integration into the genome at diverse locations[5]. Unlike functional 7SL RNA genes (RN7SL1, RN7SL2, and RN7SL3), these pseudogenes are generally not transcribed at meaningful levels, are not known to participate in signal recognition particle functions, and have not been implicated as disease genes, drug targets, or biomarkers. There is no evidence to suggest that RN7SL424P encodes a functional product or acts as a therapeutic target[1][5]. Note on correctness: RN7SL424P is not considered a true molecular target for therapeutic intervention, as it is a pseudogene and not a receptor, enzyme, transporter, or any protein-coding gene with pharmacological relevance. If a biologically functional target is intended, the query should reference RN7SL1 (7SL RNA), which is the active component of the signal recognition particle, rather than this specific pseudogene[1][4][5].

Other names
RN7SL424PRNA, 7SL, cytoplasmic 424, pseudogene
02

Biological functions

Other (pseudogenes typically have no established biological function)
03

Disease associations

Other (no disease association for this pseudogene; only the functional RN7SL1/2/3 have described biological and disease roles[4][5])

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 424, pseudogene (RN7SL424P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 424, pseudogene (RN7SL424P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call